|
PBX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.26074714504421E-12 |
| Normal-vs-Stage3 |
9.49959999996253E-07 |
| Normal-vs-Stage4 |
2.635800E-03 |
| Stage1-vs-Stage2 |
4.818000E-01 |
| Stage1-vs-Stage3 |
2.335000E-01 |
| Stage1-vs-Stage4 |
6.883600E-01 |
| Stage2-vs-Stage3 |
1.173580E-01 |
| Stage2-vs-Stage4 |
4.791000E-01 |
| Stage3-vs-Stage4 |
7.786800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.24609999996306E-06 |
| Caucasian-vs-AfricanAmerican |
2.913200E-01 |
| Caucasian-vs-Asian |
4.961600E-01 |
| AfricanAmerican-vs-Asian |
6.293200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.91970003729602E-10 |
| Male-vs-Female |
2.003700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.45790063249751E-11 |
| Normal-vs-Extreme_Weight |
1.63569158218024E-12 |
| Normal-vs-Obese |
1.06581410364015E-14 |
| Normal-vs-Extreme_Obese |
2.35699999517891E-08 |
| Normal_Weight-vs-Extreme_Weight |
8.517600E-01 |
| Normal_Weight-vs-Obese |
7.827000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.367400E-01 |
| Extreme_Weight-vs-Obese |
5.816000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.629600E-01 |
| Obese-vs-Extreme_Obese |
7.126400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21920000154086E-08 |
| Normal-vs-Age(41-60Yrs) |
3.30180327523522E-13 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.13009984387725E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.857200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.836600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.109400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.767900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.162800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
3.33066907387547E-16 |
| Normal-VS-KIRP CIMP |
2.30370000853242E-09 |
| Normal-VS-Unclassified PRCC |
1.73860004171189E-09 |
| Type1 PRCC-VS-Type2 PRCC |
9.400100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.643420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.853200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.175400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.435900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.084600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.09870000000323E-05 |
| Normal-vs-N2 |
3.016800E-03 |
| N0-vs-N1 |
6.380500E-02 |
| N0-vs-N2 |
1.885590E-01 |
| N1-vs-N2 |
9.926200E-01 |
|
|
